Tetramethylpyrazine modulates the Nrf2/JNK axis to intervene in ferroptosis and neuroinflammation after spinal cord injury: an integrated perspective from antioxidant to regenerative therapy
Molecular Biology Reports · 2026
DOI: 10.1007/s11033-026-12641-w ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Molecular Biology Reports, 2026. Verfasst von Dong Jiahao und 2 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, 650500, Yunnan, China. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Spinal Cord Injuries, Ferroptosis, Pyrazines. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The interplay between ferroptosis and neuroinflammation during secondary injury after spinal cord injury (SCI) critically drives permanent neurological dysfunction. Targeting both processes simultaneously is a promising therapeutic strategy. Tetramethylpyrazine (TMP), the main active component of Ligusticum chuanxiong, exhibits multi-target neuroprotective properties. This review systematically summarizes TMP's role in inhibiting ferroptosis and neuroinflammation after SCI by modulating the Nrf2/JNK signaling axis. We first outline TMP's chemical structure, bioavailability, and protective effects in SCI models. Next, we elucidate the Nrf2/ARE pathway as a hub for anti-ferroptosis defense and the JNK/AP-1 pathway as a driver of inflammation and apoptosis. We then explore crosstalk between these pathways via ROS, Trx-1, and p62. Existing evidence positions TMP as a "pathway crosstalk" modulator that activates Nrf2 and inhibits JNK through multiple mechanisms, including Keap1/ASK1 modification, ROS scavenging, and adaptor protein regulation. From a spatiotemporal perspective, we analyze the phased evolution of ferroptosis and inflammation, proposing TMP's time-sequential dual regulation: early-phase anti-ferroptosis and late-phase anti-inflammation. Finally, we identify current research limitations in mechanistic depth, pathway crosstalk evidence, and translational studies, and offer future directions. This review provides an integrated viewpoint for TMP in SCI treatment, a paradigm for understanding multi-target natural products, and a theoretical foundation for shifting from antioxidant to pro-regenerative strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical College, Yunnan University of Chinese Medicine, Kunming, 650500, Yunnan, China.
- Yunnan Provincial Hospital of Traditional Chinese Medicine, No. 120 Guanghua Street, Wuhua District, Kunming, 650021, Yunnan, China. henpao@126.com.
Zitieren
APA
Jiahao, D., Zirui, Z., & Tao, C. (2026). Tetramethylpyrazine modulates the Nrf2/JNK axis to intervene in ferroptosis and neuroinflammation after spinal cord injury: an integrated perspective from antioxidant to regenerative therapy. Molecular Biology Reports. https://doi.org/10.1007/s11033-026-12641-w
Vancouver
Jiahao D, Zirui Z, Tao C. Tetramethylpyrazine modulates the Nrf2/JNK axis to intervene in ferroptosis and neuroinflammation after spinal cord injury: an integrated perspective from antioxidant to regenerative therapy. Molecular Biology Reports. 2026. doi:10.1007/s11033-026-12641-w
BibTeX
@article{Jiahao2026,
author = {Jiahao, Dong and Zirui, Zhang and Tao, Chen},
title = {Tetramethylpyrazine modulates the Nrf2/JNK axis to intervene in ferroptosis and neuroinflammation after spinal cord injury: an integrated perspective from antioxidant to regenerative therapy},
journal = {Molecular Biology Reports},
year = {2026},
doi = {10.1007/s11033-026-12641-w}
}
EUVIMED